The impact of financial incentives promoting biosimilar products in oncology: A quasi-experimental study using administrative data.

The impact of financial incentives promoting biosimilar products in oncology: A quasi-experimental study using administrative data.

Show other versions (1)

<h4>Background</h4>Biosimilars have the potential to save a significant amount of money in cancer treatment costs. However, barriers exist in the adoption of biosimilar products. Japan introduced a new health policy in 2022 to promote the use of biosimilars in oncology by offering financ...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisashi Itoshima, Daisuke Takada, Etsu Goto, Noriko Sasaki, Susumu Kunisawa, Yuichi Imanaka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0312577
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items